Literature DB >> 32897691

Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.

Jiajia Hu1,2, Huanhuan Luo3,4, Qian Qu1, Xiaofeng Liao2, Chenglong Huang3, Jiayi Chen3, Zhenhai Cai3, Yi Bao3, Gang Chen3, Biao Li1, Wenguo Cui4.   

Abstract

Photothermal therapy (PTT) and photodynamic therapy (PDT) have emerged as highly prospective therapeutic modalities in cancer therapy. Notwithstanding, a critical challenge still remains in the exploration of an effective strategy to maximize the synergistic efficacy of PTT and PDT due to low photoconversion efficiency. Herein, inspired by the phospholipid bimolecular structure of the cell membrane, bionic cell membrane polymeric vesicles with photothermal/photodynamic synergy for prostate cancer therapy at one wavelength's excitation are constructed in one step by the coordination of hexadecyl trimethyl ammonium bromide (CTAB) from the surface of hydrophobic gold nanorods (AuNRs) with indocyanine green (ICG) and polycaprolactone (PCL), achieving their self-assembly in aqueous solutions. Importantly, the aggregation of the assembly improves the stability of the vesicles, realizing the synergistic effect of PTT and PDT for prostate cancer therapy. After being assembled within polymeric vesicles, bifunctional photosensitizer ICG can generate reactive oxygen species (ROS) and photothermal effect under light treatment. Their ROS not only induce PDT efficacy but also destroy the integrity of the lysosomal membrane, promoting the translocation of ICG and another photosensitizer called gold nanorods (AuNRs) into the cytosol. Moreover, their photothermal effects produced by both photosensitizers are able to engender greater damage to the tumor cells because of the close distance with organelles. This structure manifests good cellular uptake, highly effective tumor accumulation, high photothermal conversion efficiency, and excellent properties of enhanced photobleaching resistance, which are beneficial to ICG-based fluorescence tumor imaging. Using the same near-infrared (NIR) wavelength for excitation, the AuNR/ICG vesicles can reduce the side effect rate of photodamage on the skin. In addition, by generating reactive oxygen species (ROS) and double photothermal effect, the vesicles under NIR excitation can promote the apoptosis of PC3 tumor cells. Taken together, the spontaneous self-assembled AuNR/ICG vesicles exhibit huge potential in advanced-stage prostate cancer therapy, especially for the prostate-specific membrane antigen (PSMA)-negative castration-resistant subtype.

Entities:  

Keywords:  cell membrane inspired; photodynamic therapy; photothermal therapy; prostate cancer; vesicles

Mesh:

Substances:

Year:  2020        PMID: 32897691     DOI: 10.1021/acsami.0c11636

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  6 in total

Review 1.  Light-Triggered Polymersome-Based Anticancer Therapeutics Delivery.

Authors:  Elisa Hernández Becerra; Jennifer Quinchia; Cristina Castro; Jahir Orozco
Journal:  Nanomaterials (Basel)       Date:  2022-03-02       Impact factor: 5.076

Review 2.  Progress of Phototherapy Applications in the Treatment of Bone Cancer.

Authors:  Jiachen Sun; Fei Xing; Joy Braun; Frank Traub; Pol Maria Rommens; Zhou Xiang; Ulrike Ritz
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

3.  B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma.

Authors:  Yuqian Wang; Zhilong Zhao; Chenlu Liu; Miao Hao; Chenfei Kong; Xiaoming Zhao; Yiyao Gao; Yucheng Zhang; Wanxing Cui; Congxiao Zhang; Jinlan Jiang
Journal:  Int J Nanomedicine       Date:  2022-02-22

4.  Breast Cancer Cell Membrane Camouflaged Lipid Nanoparticles for Tumor-Targeted NIR-II Phototheranostics.

Authors:  Mengze Xu; Yu Yang; Zhen Yuan
Journal:  Pharmaceutics       Date:  2022-06-28       Impact factor: 6.525

Review 5.  Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities.

Authors:  Qin Xue; Jingliang Zhang; Jianhua Jiao; Weijun Qin; Xiaojian Yang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

6.  Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression.

Authors:  Jiayi Chen; Chenhong Qian; Peng Ren; Han Yu; Xiangjia Kong; Chenglong Huang; Huanhuan Luo; Gang Chen
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.